{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-102859","form_type":"8-K","ticker":"ECL","cik":"0000031462","company_name":"ECOLAB INC.","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.692255+00:00","generated_at":"2026-05-17T02:02:56.396407+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ecolab Q3 adjusted EPS $2.07 (+13% YoY), sales $4.2B (+4%), guides FY25 adjusted EPS $7.48-$7.58","bullets":["Adjusted diluted EPS $2.07, +13% YoY; reported EPS $2.05 (-21% due to prior year gain on surgical solutions sale).","Organic sales +3% led by value pricing acceleration; organic operating margin 18.7% (+110 bps).","Growth engines (Life Sciences, Pest, Global High-Tech, Ecolab Digital) grew double-digits; Institutional & Specialty organic sales +4%.","FY 2025 adjusted EPS guidance narrowed to $7.48-$7.58 (+12-14%); Q4 expected $2.02-$2.12 (+12-17%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-102859","json":"https://secwatch.observer/filing/0001104659-25-102859.json","markdown":"https://secwatch.observer/filing/0001104659-25-102859.md","text":"https://secwatch.observer/filing/0001104659-25-102859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/31462/000110465925102859/0001104659-25-102859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/31462/000110465925102859/ecl-20251028x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:02:56.396407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}